Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Dexamethasone for Diabetic Macular Edema After Cataract Surgery
NCT01030601Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexamethasone sodium phosphate in diabetic macular edema (DME) (2 arms), sponsored by University Health Network. Primary endpoint: Central Retinal Thickness at 3 months. Started Jan 2010; status: completed.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01030601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030601.